Cancer therapy shows promise against tuberculosis
A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).
Nov 16, 2023
0
8
A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).
Nov 16, 2023
0
8
Researchers at the University of Tsukuba have identified a key molecule, Themis2, within natural killer (NK) cells. These cells play a pivotal role in eliminating virus-infected cells. Themis2 remembers viral antigens and ...
Nov 16, 2023
0
6
A subtype of CD8 T cells, which are classically known to promote immune system responses, may be in fact regulating the immune system by suppressing immune cells causing self-destructive responses leading to autoimmune disorders ...
Nov 15, 2023
0
5
Removing a gene that manages stress within insulin-producing beta cells draws helpful attention from the immune system, protecting mice predisposed to type 1 diabetes from developing the disease, a new University of Wisconsin–Madison ...
Nov 10, 2023
0
22
People with Down syndrome are more likely than the general population to develop serious respiratory infections. Often, symptoms are so severe that patients require hospitalization. As respiratory season moves in, researchers ...
Nov 9, 2023
0
0
Researchers at Duke University have adapted CRISPR technologies for high-throughput screening of gene function in human immune cells and discovered that a single master regulator of the genome can be used to reprogram a network ...
Nov 9, 2023
0
60
Research published in Science Advances is the first to use a sophisticated human tissue model to explore the interaction between host and pathogen for six common species that cause urinary tract infections. The findings suggest ...
Nov 8, 2023
0
28
New research combining computer modeling and experiments with macaques shows the body's immune system helps control human immunodeficiency virus (HIV) infections largely by suppressing viral production in already infected ...
Nov 1, 2023
0
22
Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.
Nov 1, 2023
0
50
The Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against ...
Nov 1, 2023
0
21